Schindler Aktie - SHR

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

304,50

( - )

Gebot

307,00

Fragen

308,00

Volumen

0,00

0,00 Tagesbereich 0,00

294,50 52-Wochen-Bereich 317,00

Marktkapitalisierung

20,326B

Handelsende

304,50

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

66.750.813

Dividendenrendite

Kurs-Gewinn-Verhältnis

21,40

Gewinn pro Aktie (EPS)

14,23

Erlöse

11,28B

Nettogewinn

950M

Sektor

Elevators & Moving Stairways

Branche

Constr,mining,matl Handle Eq

Website

www.schindler.com

Hauptsitz

Hergiswil Lu, Che

Gegründet

1984

Schindler Holding AG is listed in the Elevators & Moving Stairways sector of the Tradegate (DE) with ticker SHR. The last closing price for Schindler was 304,50 €. Over the last year, Schindler shares have traded in a share price range of 294,50 € to 317,00 €.

Schindler currently has 66.750.813 shares in issue. The market capitalisation of Schindler is 20,33 € billion. Schindler has a price to earnings ratio (PE ratio) of 21.40.

Schindler Holding AG: Veränderungen in der Konzernleitung

Nitin Chalke, derzeit Länderchef Schindler Indien, wird in die Konzernleitung berufen und die Verantwortung für Asien-Pazifik übernehmen. Er tritt...

Schering AG and Stanford University to Cooperate in the Field of Molecular Imaging

BERLIN, November 28 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH), majority-owned by the Bayer Group, and Stanford University...

Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006

- Net Sales: +9% - Operating Profit: +20% (adjusted for one-time effects) - Betaferon(R): +16% Schering AG, Germany (FSE: SCH) continued to...

Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis

BERLIN, November 23 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH, NYSE: SHR), majority-owned by the Bayer Group, announced today...

Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma

- Twenty-five study centers currently open across the U.S. - WAYNE, N.J., Oct. 31 /PRNewswire/ -- Berlex Oncology, a business unit of Berlex...

FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis

Early Treatment With Betaseron Significantly Delayed the Time to a Second Clinical Event - Video Available WAYNE, N.J., Oct. 23 /PRNewswire/...

Family Planning Programs in the Fight Against Poverty

5th International Dialog on Population and Sustainable Development BERLIN, October 17 /PRNewswire-FirstCall/ -- "Today, on the UN's...

FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)

- YAZ is the First and Only Birth Control Pill With Proven Efficacy for PMDD - WAYNE, N.J., Oct. 5 /PRNewswire/ -- Berlex, Inc., a U.S...

Schering AG and Organon to Continue Research in Male Fertility Control Separately

BERLIN and OSS, The Netherlands, September 19 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH; NYSE: SHR) and Organon announced today...

Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & Lomb

BERLIN and ROCHESTER, New York, September 18 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH; NYSE: SHR) and Bausch & Lomb (NYSE:BOL...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	304.5	307	300.5	16	304.5125	DE
4	-1.5	-0.490196078431	306	309.5	294.5	17	301.56375839	DE
12	-1	-0.327332242226	305.5	317	294.5	35	308.4868594	DE
26	-1	-0.327332242226	305.5	317	294.5	35	308.4868594	DE
52	-1	-0.327332242226	305.5	317	294.5	35	308.4868594	DE
156	-1	-0.327332242226	305.5	317	294.5	35	308.4868594	DE
260	-1	-0.327332242226	305.5	317	294.5	35	308.4868594	DE

SHR - Frequently Asked Questions (FAQ)

What is the current Schindler share price?

The current share price of Schindler is 304,50 €

How many Schindler shares are in issue?

Schindler has 66.750.813 shares in issue

What is the market cap of Schindler?

The market capitalisation of Schindler is EUR 20,33B

What is the 1 year trading range for Schindler share price?

Schindler has traded in the range of 294,50 € to 317,00 € during the past year

What is the PE ratio of Schindler?

The price to earnings ratio of Schindler is 21,4

What is the cash to sales ratio of Schindler?

The cash to sales ratio of Schindler is 1,8

What is the reporting currency for Schindler?

Schindler reports financial results in CHF

What is the latest annual turnover for Schindler?

The latest annual turnover of Schindler is CHF 11,28B

What is the latest annual profit for Schindler?

The latest annual profit of Schindler is CHF 950M

What is the registered address of Schindler?

The registered address for Schindler is SEESTRASSE 55, HERGISWIL LU, 6052

What is the Schindler website address?

The website address for Schindler is www.schindler.com

Which industry sector does Schindler operate in?

Schindler operates in the CONSTR,MINING,MATL HANDLE EQ sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
50C0BIT Mining Ltd	4,70 € (123,81%)	4,26k
KU9WK Kellogg Co	22,87 € (52,98%)	30,99k
IGS1IGC Pharma Inc	0,462 € (47,13%)	7,24k
L7C2Windfall Geotek Inc	0,0115 € (43,75%)	10,88k
55H0MP Materials Corporation	35,50 € (38,13%)	8,29k
MAH0Mereo Biopharma Group Plc	1,62 € (-35,20%)	20,4k
EUSKore Mining Ltd	0,0095 € (-34,48%)	1,3k
2DV0Drone Volt	0,89 € (-29,70%)	357,21k
UP0Ultragenyx Pharmaceutical Inc	27,40 € (-22,60%)	376
97E0Vizsla Copper Corp	0,0602 € (-20,37%)	81,21k
ABBVolatus Aerospace Inc	0,488 € (27,08%)	16,09M
N04NuCana plc	0,064 € (20,75%)	10,86M
D7GNel ASA	0,2412 € (1,94%)	3,95M
4BHClara Technologies Corp	8,40 € (-13,40%)	3,18M
DRHDroneShield Limited	1,47 € (2,08%)	1,43M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Schindler Holding AG (SHR)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Schindler Holding AG

SHR Neueste Nachrichten

Schindler Holding AG: Veränderungen in der Konzernleitung

Schering AG and Stanford University to Cooperate in the Field of Molecular Imaging

Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006

Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis

Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma

FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis

Family Planning Programs in the Fight Against Poverty

FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)

Schering AG and Organon to Continue Research in Male Fertility Control Separately

Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & Lomb

SHR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Schindler Holding AG (SHR) Börsenkurse

Schindler Holding AG (SHR)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Schindler Holding AG

SHR Neueste Nachrichten

Schindler Holding AG: Veränderungen in der Konzernleitung

Schering AG and Stanford University to Cooperate in the Field of Molecular Imaging

Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006

Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis

Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma

FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis

Family Planning Programs in the Fight Against Poverty

FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)

Schering AG and Organon to Continue Research in Male Fertility Control Separately

Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & Lomb

SHR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen